Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells

Placenta-derived decidua stromal cells (DSCs) are being investigated as an alternative to other sources of mesenchymal stromal cells (MSCs) for cellular therapy. DSCs are more effective in treating acute inflammatory diseases in human and this is our preclinical safety study of human DSCs in Sprague...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Behnam Sadeghi, Gianluca Moretti, Fabian Arnberg, Erik Samén, Bita Kohein, Rusan Catar, Julian Kamhieh-Milz, Sven Geissler, Guido Moll, Staffan Holmin, Olle Ringdén
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019-11-01
Colecção:Frontiers in Immunology
Assuntos:
placenta-derived decidua stromal cells
mesenchymal stromal cells
toxicity
side effects
cellular therapy
Acesso em linha:https://www.frontiersin.org/article/10.3389/fimmu.2019.02685/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados